Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.
about
Interventions for treating AIDS-associated Hodgkin´s lymphoma in treatment-naive adultsInterventions for treating AIDS-associated Hodgkin´s Lymphoma in treatment-naive adults with AIDSNon-AIDS definings malignancies among human immunodeficiency virus-positive subjects: Epidemiology and outcome after two decades of HAART eraThe rising challenge of non-AIDS-defining cancers in HIV-infected patientsThe evolving scenario of non-AIDS-defining cancers: challenges and opportunities of careNew treatment strategies for HIV-positive cancer patients undergoing antiblastic chemotherapy.Blood and marrow transplant for lymphoma patients with HIV/AIDS.Hodgkin's Disease in Patients with HIV InfectionEBV and HIV-Related LymphomaHuman Immunodeficiency Virus Infection and Hodgkin's Lymphoma in South Africa: An Emerging ProblemTreatment options of AIDS-related lymphoma.Should HIV-positive patients with lymphoma be offered stem cell transplants?Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020.Antitumour effects of antiretroviral therapy.Evolving spectrum and incidence of non-AIDS-defining malignancies.HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.Stem cell transplantation for lymphoma patients with HIV infection.Classical Hodgkin's lymphoma arising in different host's conditions: pathobiology parameters, therapeutic options, and outcome.Hodgkin lymphoma in patients with HIV infection: a review.Diagnosis and management of lymphomas and other cancers in HIV-infected patients.Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG).Decision-making in the management of adult classical Hodgkin's lymphoma: determining the optimal treatment.Hodgkin lymphoma in the elderly, pregnant, and HIV-infected.Ongoing change in the treatment of HIV-associated malignancies in the HAART era.HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART.Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trialPrognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective studManaging HIV and Hodgkin lymphoma in the twenty-first century.Long-term follow up of patients with human immunodeficiency virus infection and advanced stage Hodgkin's lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine.Limited prognostic value of the International Prognostic Score in advanced stage human immunodeficiency virus infection-related Hodgkin lymphoma treated with the doxorubicin, bleomycin, vinblastine, and dacarbazine regimen.Profound neutropenia resulting from interaction between antiretroviral therapy and vinblastine in a patient with HIV-associated Hodgkin's disease.Clinical characteristics of human immunodeficiency virus-associated Hodgkin lymphoma patients in Japan.Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease.Intracerebral progression of Hodgkin lymphoma in a man with HIV.HIV-related lymphoma
P2860
Q24245321-860ECDBE-423D-4E83-9784-885A86354860Q24245877-1F57382C-DBA1-477D-A2BC-39BB6CC895D6Q26797897-3C2E2471-4B0C-4288-B282-5C418BCF55E2Q26861496-5039ADA6-465E-4421-BCD1-50296E1D113EQ26991549-FB3517D3-27DC-4769-A9F8-3416DFA7CAF8Q30244166-EFC5CD15-CC94-4FB3-B6AC-98EF2BEFC183Q34068528-3807707E-2BCD-435F-B006-1EF964301408Q34169941-B0BD81F3-9116-40AB-8FAE-9DE51A7A475DQ34549450-EDA0B7AB-59E4-4AF3-BF06-E52893BDA7B1Q34571564-6417E4D1-137B-472F-AE24-C1647D954E5EQ35183751-1B452094-F71F-4C6B-9C66-F43466CEA2E6Q35547755-AC69C868-ED85-4F1A-9DF9-3A5787FA6FBAQ35915648-C32D30ED-EB68-4DF0-BE18-EE44AD643919Q35934144-A709C0A2-6810-4C70-B137-42E7FEFE37C5Q37353390-55429D43-FE80-443A-92B7-CF5F1BB40BF0Q37658727-527B0351-C4DC-49AA-BE06-6599273F6D41Q37793405-83178F6D-CA57-4024-8740-8FC22ACF92C2Q37832198-41D89E4A-E701-4E75-B104-190B240A3DB9Q38006636-BEA1943E-5C8E-4E89-9C80-316A1F084C0AQ38194845-6BD07F82-7A7F-4D08-8DFE-2826B873ABDBQ38210131-6B53F688-91AC-45FF-96C2-63428D1F9D29Q38337152-4262618E-B52C-4D02-BC5A-F6866655301DQ38920105-F255C33C-61ED-41C7-962C-355797298A1FQ39207881-4999099C-270F-4910-A684-46F238CC1DADQ40512007-E7B6B266-BEAF-4982-B1A1-4381B531E9FFQ40702849-88E2056F-4300-48DB-B2B3-FF9EA93D0D86Q41728053-235DC4D0-5486-46CE-8963-5FE5C273A483Q42213911-7D51E2CC-965D-452D-82E5-B39306D5CCFAQ43065877-F1780189-E88A-4414-8E20-998E00D57C78Q43276004-08DD02DA-44F8-4A0B-8E19-7ACABFE45A46Q45172725-82456552-86D6-4392-AFB5-0DEA847E813DQ45356450-F40CBF31-0F38-4A31-8848-CBB7717F78B3Q45640458-DE9B293E-C719-4BAA-8E5B-DD9D0DA35B6EQ48398047-A9179DA3-0872-4197-B34F-4C968AE3DA7AQ56112360-17EF7FC6-BE0A-455E-B6ED-60056C1C2ED4
P2860
Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Stanford V regimen and concomi ...... kin disease and HIV infection.
@en
Stanford V regimen and concomi ...... kin disease and HIV infection.
@nl
type
label
Stanford V regimen and concomi ...... kin disease and HIV infection.
@en
Stanford V regimen and concomi ...... kin disease and HIV infection.
@nl
prefLabel
Stanford V regimen and concomi ...... kin disease and HIV infection.
@en
Stanford V regimen and concomi ...... kin disease and HIV infection.
@nl
P2093
P1433
P1476
Stanford V regimen and concomi ...... gkin disease and HIV infection
@en
P2093
Andrea Antinori
Clara Schiantarelli
Emanuela Vaccher
Ezio Nigra
Giampiero di Gennaro
Giuseppe Rossi
Jean Gabarre
Marco Fasan
Maurizio Mena
Renato Talamini
P304
P356
10.1182/BLOOD-2002-03-0989
P407
P577
2002-09-01T00:00:00Z